Embecta Corp. (EMBC) stock
EMBCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 15/3079% below fair value
$6.46+0.03 (+0.47%)
Close on Nov 13, 2026Market cap $366.02MP/E 4.4Yield 9.29%
Embecta price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Embecta's price to sales ratio was 0.4× on Nov 11, 2026, against 0.7× a year earlier. Over the last 5 years it ranged from 0.2× to 1.7×, with a median of 0.8×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.4× | −0.3 |
| 2025 | Dec 31, 2025 | 0.6× | −0.4 |
| 2024 | Dec 31, 2024 | 1.1× | +0.1 |
| 2023 | Dec 29, 2023 | 1.0× | −0.3 |
| 2022 | Dec 30, 2022 | 1.3× | – |
See a number that looks wrong?